BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peura DA, Crowe SE. Helicobacter pylori. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00050-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shul'gina E, Simonova Z. CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF H. PYLORI-ASSOCIATED GASTRODUODENAL ZONE DISEASES: AGE-RELATED ASPECTS. Ulyanovsk Medico-biological Journal 2021. [DOI: 10.34014/2227-1848-2021-4-89-99] [Reference Citation Analysis]
2 Popescu D, Andronescu D, Babeș PA. Association Between Helicobacter Pylori Infection and Insulin Resistance: A Systematic Review. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2017;24:149-154. [DOI: 10.1515/rjdnmd-2017-0019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kasap E, Demirci U, Buran T, Yüceyar H. Otoimmün karaciğer hastalıklarında Helicobacter pylori ve üst gastrointestinal endoskopi bulgularının sıklığı. Endoskopi Gastrointestinal 2017. [DOI: 10.17940/endoskopi.466540] [Reference Citation Analysis]
4 Maev IV, Andreev DN, Kucheryavyi YA. [Helicobacter pylori infection and extragastroduodenal diseases]. Ter Arkh 2015;87:103-10. [PMID: 28635878 DOI: 10.17116/terarkh2015878103-110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Rakici H, Akdoğan RA, Bedir R, Copur A, Yilmaz A. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. J Dig Dis 2014;15:508-13. [PMID: 24980811 DOI: 10.1111/1751-2980.12171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
6 Sostres C, Gargallo CJ, Lanas A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights. World J Gastroenterol 2014; 20(28): 9439-9450 [PMID: 25071338 DOI: 10.3748/wjg.v20.i28.9439] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
7 Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: Current status and future concepts. World J Gastroenterol 2014; 20(18): 5283-5293 [PMID: 24833858 DOI: 10.3748/wjg.v20.i18.5283] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 116] [Article Influence: 12.1] [Reference Citation Analysis]